In today’s Pharmaceutical Executive Daily, Public Citizen files suit over undisclosed drug pricing agreements involving ...
Pharmaceutical Executive: What AI trends did you see at the 2026 JP Morgan Healthcare Conference? Angela Schwab: Good and bad. You see a lot of players coming into the market saying that they can do ...
When you can’t find specialized talent in the usual places, it undermines timelines for R&D, clinical trials, and commercialization. But there are other locations that employers can explore when ...
AstraZeneca entered a strategic collaboration with CSPC Pharmaceuticals to expand its weight management and metabolic disease ...
The deal underscores a broader shift in autoimmune drug development toward therapies that aim to reprogram disease-driving ...
The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...
Teva's Honestly HD campaign, featuring Will Forte, aims to raise awareness about Huntington's disease through personal ...
A. Douglas Bender is an associate professor of management in the School of Business Management of Widener University, Chester, PA, where he teaches graduate courses in managed care organizations and ...
Lou Pillai is the founder of Ulivmo and most recently, he was the Head of Data and Digital at Immunomedics (acquired by Gilead). Ehsan Ehsani is a director of consulting at CGI and leader of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results